Strs Ohio Has $807,000 Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Strs Ohio lessened its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 9.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,500 shares of the company’s stock after selling 4,600 shares during the quarter. Strs Ohio owned approximately 0.17% of ZimVie worth $807,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Monarch Capital Management Inc. grew its holdings in shares of ZimVie by 8.4% during the 4th quarter. Monarch Capital Management Inc. now owns 67,447 shares of the company’s stock worth $1,197,000 after purchasing an additional 5,199 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of ZimVie by 27.2% during the 4th quarter. SG Americas Securities LLC now owns 14,152 shares of the company’s stock worth $251,000 after purchasing an additional 3,029 shares in the last quarter. Kennedy Capital Management LLC lifted its position in shares of ZimVie by 6.1% during the 3rd quarter. Kennedy Capital Management LLC now owns 386,403 shares of the company’s stock worth $3,636,000 after buying an additional 22,175 shares during the period. Beryl Capital Management LLC bought a new position in shares of ZimVie during the 3rd quarter worth approximately $835,000. Finally, Natixis Advisors L.P. bought a new position in shares of ZimVie during the 3rd quarter worth approximately $813,000. Institutional investors and hedge funds own 95.63% of the company’s stock.

ZimVie Trading Down 1.5 %

Shares of ZIMV opened at $15.81 on Thursday. The stock has a fifty day moving average price of $17.23 and a two-hundred day moving average price of $14.49. The company has a current ratio of 2.78, a quick ratio of 2.32 and a debt-to-equity ratio of 1.26. ZimVie Inc. has a 52-week low of $6.52 and a 52-week high of $20.91.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Wednesday, February 28th. The company reported $0.10 earnings per share (EPS) for the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%. The firm had revenue of $113.07 million during the quarter.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Thursday, April 11th. Barclays raised their target price on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research report on Tuesday, March 5th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.